Savant Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.53K Sell
612
-3,834
-86% -$28.4K ﹤0.01% 1843
2025
Q1
$38.3K Buy
+4,446
New +$38.3K ﹤0.01% 1553